Merck Acquires Harpoon Therapeutics for $680 Million
In a major move, pharmaceutical giant Merck has announced its acquisition of immunotherapy company Harpoon Therapeutics for $680 million....
clinical-stage immunotherapy company
PDS Biotechnology Shares Rise 20% After Narrower-Than-Expected 3Q Loss
PDS Biotechnology, a clinical-stage immunotherapy company, saw a 20% increase in shares to $6.30 after reporting a narrower-than-expected third-quarter...
Alpine Immune Shares Fall After Public Offering
Shares of Alpine Immune Sciences dropped nearly 10% in premarket trading on Tuesday after the company priced its $150...